Analysts at Truist Securities admitted that the result for itepekimab, which the companies were hoping to follow their ...

Regeneron Pharmaceuticals stock slumped on Friday after two late-stage trials for an experimental drug co-developed with ...

Bimekizumab demonstrated a favorable safety profile for the long-term treatment of axSpA and PsA, with rates of TEAEs remaining stable over time.

This study presents an important finding on the role of GATA4 in aging and OA-associated cartilage pathology. The evidence supporting the conclusions is compelling, with rigorous in vitro and in vivo ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Creative Biolabs recently updated its antibody chip platform, expanding product arrays for phosphorylation signaling and ...

Q: I am severely obese, and my doctor says I have to take immediate actions — medical and personal — or really bad things ...